Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants

Early Human Development

Volumn 74, Issue 1, 2003, Pages 37-45

  Walther, Frans J ^a,b   Findlay, Richard D ^a   Durand, Manuel ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bronchopulmonary dysplasia; Respiratory distress syndrome; Serum cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; TETRACOSACTIDE;

ADRENAL FUNCTION; ADRENAL SUPPRESSION; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN TEST; DIGESTIVE SYSTEM PERFORATION; DOUBLE BLIND PROCEDURE; DRUG SCREENING; EXTUBATION; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; INFANT; LEUKOMALACIA; LOW DRUG DOSE; LUNG COMPLIANCE; MENINGITIS; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; PATIENT COMPLIANCE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHORT COURSE THERAPY; WEANING;

EID: 0141739516     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(03)00082-3     Document Type: Article

References (28)

1. Northway W.H. Jr., Rosan R.C., Porter D.Y. Pulmonary disease following respiratory therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276:1967;357-368.
2. Jobe A.H. The new BPD: an arrest of lung development. Pediatr. Res. 46:1999;641-643.
3. Jobe A.H., Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annu. Rev. Physiol. 62:2000;825-846.
4. Durand M., Sardesai S., McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics. 95:1995;584-590.
5. Brozanski B.S., Jones J.G., Gilmour C.H., Balsan M.J., Vazquez R.L., Israel B.A.et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J. Pediatr. 126:1995;769-776.
6. Halliday H.L., Ehrenkranz R.A. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). The cochrane library. vol. 2:2002;Update Software, Oxford.
7. Wilson D.M., Baldwin R.B., Ariagno R.L. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J. Pediatr. 113:1988;764-768.
8. Alkalay A.L., Pomerance J.J., Puri A.R., Lin B.J.C., Vinstein A.L., Neufeld N.D.et al. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics. 86:1990;204-210.
9. Rizvi Z.B., Aniol H.S., Myers T.F., Zeller W.P., Fisher S.G., Anderson C.L. Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J. Pediatr. 120:1992;961-965.
10. Kari M.A., Raivio K.O., Stenman U.-H., Voutilainen R. Serum cortisol, dehydroepiandrosterone sulfate, and steroid- binding globulins in preterm neonates: effects of gestational age and dexamethasone therapy. Pediatr. Res. 40:1996;319-324.
11. Ng P.C., Wong G.W.K., Lam C.W.K., Lee C.H., Fok T.F., Wong M.Y.et al. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J. Clin. Endocrinol. Metab. 82:1997;2429-2432.
12. Merz U., Pfäffle R., Peschgens Th., Hörnchen H. The hypothalamic-pituitary-adrenal axis in preterm infants weighing <1250 g: association with perinatal data and chronic lung disease. Acta Paediatr. 87:1998;313-317.
13. Durand M., Mendoza M.E., Tantivit P., Kugelman A., McEvoy C. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics. 109:2002;262-268.
14. Korte C., Styne D., Merritt T.A., Mayes D., Wertz A., Helbock H.J. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J. Pediatr. 128:1996;257-263.
15. Karlsson R., Kallio J., Toppari J., Kero P. Timing of peak serum cortisol values in preterm infants in low-dose and the standard ACTH tests. Pediatr. Res. 45:1999;367-369.
16. Yeh T.F., Torre J.A., Rastogi A., Anyebuno M.A., Pildes R.S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J. Pediatr. 117:1990;273-282.
17. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver R.G.et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 104:1999;15-21.
18. Yeh T.F., Lin Y.J., Huang C.C., Chen Y.J., Lin C.H., Lin H.C.et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 101:1998;e7.
19. Shinwell E.S., Karplus M., Reich D., Weintraub Z., Blazer S., Bader D.et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch. Dis. Child, Fetal Neonatal Ed. 83:2000;F177-F181.
20. Halliday H.L., Ehrenkranz R.A. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). The cochrane library. vol. 2:2002;Update Software, Oxford.
21. National Institutes of Health Consensus Development Panel Antenatal corticosteroids revisited: repeat courses-NIH consensus development conference statement, August 17-18, 2000. Obstet. Gynecol. 98:2001;144-150.
22. Watterberg K.L., Scott S.M. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics. 95:1995;120-125.
23. Al Saedi S., Dean H., Dent W., Cronin C. Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J. Pediatr. 126:1995;985-987.
24. Ng P.C., Wong G.W.K., Lam C.W.K., Lee C.H., Wong M.Y., Fok T.F.et al. Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J. Clin. Endocrinol. Metab. 82:1997;3548-3552.
25. Ng P.C., Wong G.W.K., Lam C.W.K., Lee C.H., Fok T.F., Wong M.Y.et al. Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch. Dis. Child, Fetal Neonatal. Ed. 80:1999;F213-F216.
26. Stark A.R., Carlo W.A., Tyson J.E., Papile L.-A., Wright L.L., Shankaran S.et al. National Institute of Child Health and Human Development Neonatal Research Network. Adverse effects of early dexamethasone treatment in extremely low-birth-weight infants. N. Engl. J. Med. 344:2001;95-101.
27. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics. 108:2001;741-748.
28. American Academy of Pediatrics Committee on fetus and newborn and Canadian pediatric society, fetus and newborn committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 109:2002;330-338.